| Literature DB >> 25009180 |
Koji Takeo1, Shun Tanimura2, Takehiro Shinoda3, Satoko Osawa1, Ivan Krasmirov Zahariev2, Naoki Takegami4, Yoshiko Ishizuka-Katsura3, Naoko Shinya3, Shizuka Takagi-Niidome1, Aya Tominaga1, Noboru Ohsawa3, Tomomi Kimura-Someya3, Mikako Shirouzu3, Satoshi Yokoshima2, Shigeyuki Yokoyama5, Tohru Fukuyama2, Taisuke Tomita6, Takeshi Iwatsubo7.
Abstract
γ-Secretase is an intramembrane-cleaving protease responsible for the generation of amyloid-β (Aβ) peptides. Recently, a series of compounds called γ-secretase modulators (GSMs) has been shown to decrease the levels of long toxic Aβ species (i.e., Aβ42), with a concomitant elevation of the production of shorter Aβ species. In this study, we show that a phenylimidazole-type GSM allosterically induces conformational changes in the catalytic site of γ-secretase to augment the proteolytic activity. Analyses using the photoaffinity labeling technique and systematic mutational studies revealed that the phenylimidazole-type GSM targets a previously unidentified extracellular binding pocket within the N-terminal fragment of presenilin (PS). Collectively, we provide a model for the mechanism of action of the phenylimidazole-type GSM in which binding at the luminal side of PS induces a conformational change in the catalytic center of γ-secretase to modulate Aβ production.Entities:
Keywords: Alzheimer’s disease; allosteric modulator; amyloid-β protein; chemical biology; intramembrane proteolysis
Mesh:
Substances:
Year: 2014 PMID: 25009180 PMCID: PMC4115564 DOI: 10.1073/pnas.1402171111
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205